Dr. Agarwal's Health Care: Scheme of Amalgamation Effective Nov 1, Record Date Nov 18
Dr. Agarwal's Health Care Limited's Board approved the Scheme of Amalgamation, effective November 1, 2026. The authorized share capital will increase to ₹110 crore. The Record Date for share allotment is November 18, 2026, with an exchange ratio of 23:2.
The scheme of amalgamation is a major corporate action that will result in the combined entity having an increased authorized share capital and a clear effective date and record date for share exchange, significantly impacting the company's structure and shareholders.
The announcement details the successful progression and effectiveness of a scheme of amalgamation, which is a significant corporate restructuring event. This is generally viewed positively as it indicates progress and consolidation for the company.
Dr. Agarwal's Health Care Limited has announced the outcome of its Board Meeting held on October 20, 2026. The Board noted and approved the effectiveness of the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The NCLT's sanction order, dated September 30, 2026, was taken on record, and with the filing of the order with the Registrar of Companies on October 15, 2026, all conditions for the scheme's effectiveness have been satisfied.
The Scheme of Amalgamation will become effective from November 01, 2026, with the Appointed Date being April 01, 2026. The Board also approved the alteration of the authorized share capital of the company. Upon the scheme becoming effective, the authorized share capital of Dr. Agarwal’s Health Care Limited will increase from ₹90,00,00,000 to ₹110,00,00,000.
Furthermore, Wednesday, November 18, 2026, has been fixed as the Record Date for determining eligible equity shareholders of Dr. Agarwal’s Eye Hospital Limited who will receive consideration shares. The share exchange ratio is 23 equity shares of ₹1 each of Dr. Agarwal’s Health Care Limited for every 2 equity shares of ₹10 each held in Dr. Agarwal’s Eye Hospital Limited. The Board Meeting commenced at 05:30 P.M. IST and concluded at 06:00 P.M. IST.
What to do with a filing like this
Dr. Agarwal's Health Care Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Agarwal's Health Care Limited. Read the original for the full detail.